drugset / Trial / NCT01420510
Saginil in vs. Placebo for Gynecologic Oncology Patients Affected by Vaginitis
RandomizedParallel-groupQuadruple-blindPrevention
Summary
We hypothesise that the use of Adelmidrol (Saginil in vaginal cannulas) can reduce the incidence and magnitude of vaginitis in patients affected by gynecologic malignancies.
Timeline
- Start
- 2011-09
- Primary completion
- 2014-11
- Completion
- 2014-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Adelmidrol | Small molecule | — | Other |